MGO One Seven’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
MGO One Seven's BMY Position: Q2 2026 in Review
MGO One Seven reduced its Bristol-Myers Squibb (BMY) stake by 9.5% in Q2 2026, selling an estimated $244K and leaving 40,184 shares worth $2.32M. The position accounts for 0.04% of the portfolio, ranked #449.
MGO One Seven first reported a position in BMY in Q4 2017 and has held it in 30 quarters since. The position peaked at $2.81M in Q1 2023. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- MGO One Seven held 40,184 shares of Bristol-Myers Squibb worth $2.32M as of Q2 2026.
- MGO One Seven sold 4,241 Bristol-Myers Squibb shares in Q2 2026, an estimated $244K.
- Bristol-Myers Squibb made up 0.04% of MGO One Seven's portfolio in Q2 2026, its #449 holding.
- MGO One Seven first reported a position in Bristol-Myers Squibb in Q4 2017 and has held it in 30 quarters since.
- MGO One Seven's Bristol-Myers Squibb position peaked at $2.81M in Q1 2023.
- 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on MGO One Seven's 13F filing for Q2 2026, filed 31 Jul 2026.